Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Alunbrig
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alunbrig 180mg tablets
0801050CPBBAAAA
|
Alunbrig | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Alunbrig 30mg tablets
0801050CPBBABAB
|
Alunbrig | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Alunbrig 90mg tablets
0801050CPBBACAC
|
Alunbrig | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Alunbrig 90mg/180mg tablets treatment initiation pack
0801050CPBBADAD
|
Alunbrig | Brigatinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.